Long-Acting Bronchodilator Approved long-acting inhaled bronchodilator from Glaxo, Research Triangle Park, N.C., has been approved by the Food and Drug Administration for treating asthma. The bronchodilator is said to be the first that is effective for up to 12 hours, enabling it to ease nocturnal symptoms in asthma patients. Patients take two doses a day (each dose equals two actuations or puffs), in the morning and evening. Each 13-g canister contains 120 actuations, a one-month supply. ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.